What Turnstone Biologics Corp.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Versant Ventures V, Llc | 10% owner | Aug 08 | Tender Offer · U | −274,990 | — | — | 0 |
| Versant Ventures V, Llc | 10% owner | Aug 08 | Tender Offer · U | −82,006 | — | — | 0 |
| Versant Ventures V, Llc | 10% owner | Aug 08 | Tender Offer · U | −90,888 | — | — | 0 |
| Versant Ventures V, Llc | 10% owner | Aug 08 | Tender Offer · U | −207,486 | — | — | 0 |
| Versant Ventures V, Llc | 10% owner | Aug 08 | Tender Offer · U | −2,726,322 | — | — | 0 |
| Orbimed Advisors Llc | Director | Aug 08 | Tender Offer · U | −3,099,265 | — | — | 0 |
| Gupta Rishi | Director | Aug 08 | Tender Offer · U | −3,099,265 | — | — | 0 |
| Jerel Davis | Director | Aug 08 | Tender Offer · U | −82,006 | — | — | 0 |
| Jerel Davis | Director | Aug 08 | Tender Offer · U | −90,888 | — | — | 0 |
| Jerel Davis | Director | Aug 08 | Tender Offer · U | −207,486 | — | — | 0 |
| Jerel Davis | Director | Aug 08 | Tender Offer · U | −2,726,322 | — | — | 0 |
| Jerel Davis | Director | Aug 08 | Tender Offer · U | −274,990 | — | — | 0 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Open-market buy · P | +5,939 | $12.00 | +$71.3K | 82,006 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Open-market buy · P | +6,575 | $12.00 | +$78.9K | 90,888 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Open-market buy · P | +15,028 | $12.00 | +$180K | 207,486 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Open-market buy · P | +197,458 | $12.00 | +$2.37M | 2,726,322 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Derivative Conversion · C | +274,990 | — | — | 274,990 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Derivative Conversion · C | +76,067 | — | — | 76,067 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Derivative Conversion · C | +84,313 | — | — | 84,313 |
| Versant Ventures V, Llc | 10% owner | Jul 25 | Derivative Conversion · C | +192,458 | — | — | 192,458 |
Loading...
